FGFR3 | 肾上腺癌,膀胱癌,癌症,肺腺癌,骨髓瘤,皮肤黑色素瘤,thanatophoric发育不良,最常见的形式是散发性,致死性侏儒症,尿路上皮癌 | AZ12908010,AZD4547,Infigratinib,Infigratinib,多韦替尼,厄达替尼,厄达替尼,帕唑帕尼,培唑帕尼,PD173074,SU5402,维莫非尼, | | 20 | 29 |
FLT3 | 急性髓细胞白血病,急性早幼粒细胞白血病,成人B淋巴细胞白血病,结直肠癌,肾细胞癌 | Tyrphostin,All-trans Retinoic Acid,AS602868,Gilteritinib,JQ1,Lestaurtinib (CEP-701),米哚妥林,坦度替尼,尼洛替尼,哌柏西利,帕博西尼,帕博西林,帕纳替尼/普纳替尼/波纳替尼,奎扎替尼,Quizartinib (AC220),瑞戈非尼,司美替尼,索拉非尼,舒尼替尼,SU5614,舒尼替尼, | 蒽环类,阿糖胞苷,柔红霉素, | 15 | 82 |
FGFR2 | 乳腺癌,癌,胆管癌,子宫内膜癌,肝细胞癌,肺腺癌,卵巢透明细胞癌,乳头状肾细胞癌,直肠癌,胃癌,尿路上皮癌 | 46834118,AZD4547,Infigratinib,Infigratinib,Derazantinib,多韦替尼,厄达替尼,氟维司群,厄达替尼,帕唑帕尼,培唑帕尼,PD173074,帕纳替尼/普纳替尼/波纳替尼,Futibatinib, | | 12 | 29 |
FBXW7 | 癌症,结直肠癌,肾细胞癌,T细胞急性淋巴细胞白血病 | 西妥昔单抗,依维莫司,MTOR Inhibitors,帕尼单抗,西罗莫司,瑞戈非尼, | | 9 | 12 |
FGFR1 | 膀胱癌,骨尤因肉瘤,乳腺癌,癌症,慢性骨髓单核细胞白血病,慢性骨髓增生性疾病,结直肠癌,雌激素受体阳性乳腺癌,胃腺癌,头颈部鳞状细胞癌,血液癌,肺癌,非小细胞肺癌,肺鳞状细胞癌细胞癌,小儿低级别胶质瘤(PLGG),毛细胞性星形细胞瘤,肉瘤 | AZD4547,Infigratinib,Infigratinib,多韦替尼,Dovitinib Dilactic Acid (TKI258 Dilactic Acid),FGF/VEGF Receptor Tyrosine Kinase Inhibitor,PD173074,米哚妥林,帕唑帕尼,培唑帕尼,帕纳替尼/普纳替尼/波纳替尼, | 4-羟基他莫昔芬, | 7 | 32 |
FOXO1 | 肺泡横纹肌肉瘤 | Bromodomain Inhibitor, | | 2 | 3 |
FOS | 骨上皮样血管瘤 | 厄贝沙坦, | | 2 | 2 |
FLCN | 乳头状肾细胞癌 | 依维莫司,Sirolimus [USAN:BAN:INN], | | 2 | 2 |
FLI1 | 尤因肉瘤 | | | 2 | 2 |
FOXP1 | 弥漫性大B细胞淋巴瘤 | | | 1 | 1 |
FOXL2 | 卵巢颗粒细胞瘤 | | | 1 | 2 |
FANCA | 前列腺癌 | | 顺铂, | 1 | 1 |
FANCC | 胰腺癌 | 马法兰,米尔法兰,丝裂霉素C, | 苯丁酸氮芥,顺铂,吉西他滨, | 1 | 1 |
FCGR2A | 乳腺癌 | | | 1 | 2 |
FCGR2B | 乳腺癌 | | | 1 | 1 |
FCGR3A | 乳腺癌 | 曲妥珠单抗, | | 1 | 2 |
FGF2 | 急性髓性白血病 | Quizartinib (AC220), | | 1 | 1 |
FGF3 | 乳腺癌,肝细胞癌 | 多韦替尼,索拉非尼, | | 1 | 2 |
FGF13 | 前列腺癌 | | | 1 | 1 |
FGFR4 | 肺泡横纹肌肉瘤,Her2受体阳性乳腺癌 | 多韦替尼,FGF/VEGF Receptor Tyrosine Kinase Inhibitor,PD173074,帕纳替尼/普纳替尼/波纳替尼, | | 1 | 2 |
FOXO3 | 脉络丛癌 | | | 1 | 2 |
FLT4 | 血管肉瘤 | 帕唑帕尼,培唑帕尼, | | 1 | 1 |
FNTB | 卵巢癌 | | 洛那法尼, | 1 | 1 |
FOXP3 | 乳腺癌 | | 表柔比星, | 1 | 1 |
FGF6 | | | | 0 | 0 |
FAS | | | | 0 | 0 |
FGF10 | | | | 0 | 0 |
FGF14 | | | | 0 | 0 |
FGF19 | | | | 0 | 0 |
FGF23 | | | | 0 | 0 |
FGF4 | | | | 0 | 0 |
FUBP1 | | | | 0 | 0 |
FLT1 | | | | 0 | 0 |
FRS2 | | | | 0 | 0 |
FANCI | | | | 0 | 0 |
FANCM | | | | 0 | 0 |
FANCD2 | | | | 0 | 0 |
FANCE | | | | 0 | 0 |
FANCF | | | | 0 | 0 |
FANCG | | | | 0 | 0 |
FANCL | | | | 0 | 0 |
FAT1 | | | | 0 | 0 |
FH | | | | 0 | 0 |
FAM135B | | | | 0 | 0 |
FANCB | | | | 0 | 0 |
FAT3 | | | | 0 | 0 |
FGF12 | | | | 0 | 0 |
FGF7 | | | | 0 | 0 |
FGR | | | | 0 | 0 |
FOXA1 | | | | 0 | 0 |
FRK | | | | 0 | 0 |
FYN | | | | 0 | 0 |
FCGR1A | | | | 0 | 0 |
FAM175A | | | | 0 | 0 |
FAM46C | | | | 0 | 0 |
F13A1 | | | | 0 | 0 |
F3 | | | | 0 | 0 |
F8 | | | | 0 | 0 |
FAF1 | | | | 0 | 0 |
FAM131B | | | | 0 | 0 |
FAM149A | | | | 0 | 0 |
FAM153B | | | | 0 | 0 |
FAM155A | | | | 0 | 0 |
FAM157B | | | | 0 | 0 |
FAN1 | | | | 0 | 0 |
FAP | | | | 0 | 0 |
FASLG | | | | 0 | 0 |
FAT2 | | | | 0 | 0 |
FAT4 | | | | 0 | 0 |
FBN2 | | | | 0 | 0 |
FBXL7 | | | | 0 | 0 |
FBXO11 | | | | 0 | 0 |
FCGR2C | | | | 0 | 0 |
FCGR3B | | | | 0 | 0 |
FCRL4 | | | | 0 | 0 |
FES | | | | 0 | 0 |
FGA | | | | 0 | 0 |
FGD1 | | | | 0 | 0 |
FGD4 | | | | 0 | 0 |
FGF16 | | | | 0 | 0 |
FHIT | | | | 0 | 0 |
FIP1L1 | | | | 0 | 0 |
FKBP5 | | | | 0 | 0 |
FLG | | | | 0 | 0 |
FLNA | | | | 0 | 0 |
FLNC | | | | 0 | 0 |
FLOT1 | | | | 0 | 0 |
FMN2 | | | | 0 | 0 |
FMO1 | | | | 0 | 0 |
FMR1 | | | | 0 | 0 |
FN1 | | | | 0 | 0 |
FNDC4 | | | | 0 | 0 |
FNTA | | | | 0 | 0 |
FOLH1 | | | | 0 | 0 |
FOLR3 | | | | 0 | 0 |
FOXA2 | | | | 0 | 0 |
FOXO4 | | | | 0 | 0 |
FOXQ1 | | | | 0 | 0 |
FPGS | | | | 0 | 0 |
FRAS1 | | | | 0 | 0 |
FRG1 | | | | 0 | 0 |
FRMPD4 | | | | 0 | 0 |
FRYL | | | | 0 | 0 |
FSCB | | | | 0 | 0 |
FUS | | | | 0 | 0 |
FXR1 | | | | 0 | 0 |
FZD1 | | | | 0 | 0 |
FZD10 | | | | 0 | 0 |
FZR1 | | | | 0 | 0 |